Across TCGA pan-cancer cohorts, LINC02629 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of LINC02629’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where LINC02629 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02629 is over-expressed in tumor, although a few such as BRCA show the opposite, repressed pattern.

LIHC, BRCA, and KIRP are the cancer types where LINC02629 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02629 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	All	All	+0.091	.004	5	view →
BRCA	Female	All	−0.026	.020	2	view →
KIRP	Female	All	+0.086	.041	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: LINC02629 RNA expression & survival · all LINC02629 data types